CC
ROIVW

Centiva Capital’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Centiva Capital’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,020,940
Closed -$788K – 1742
2022
Q3 		$788K Buy
2,020,940
+199,050
+11% +$106K 0.01% 721
2022
Q2 		$1.09M Sell
1,821,890
-2,900
-0.2% -$1.52K 0.03% 569
2022
Q1 		$1.61M Buy
1,824,790
+721,883
+65% +$917K 0.03% 510
2021
Q4 		$2.24M Buy
+1,102,907
New +$1.68M 0.05% 339

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Centiva Capital's ROIVW Position: Q4 2022 in Review

Centiva Capital sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q4 2022, closing a stake of 2,020,940 shares — an estimated $788K sold.

Centiva Capital first reported a position in ROIVW in Q4 2021 and held it in 4 quarters. The position peaked at $2.24M in Q4 2021. 28 funds tracked by Wall St. Rank hold ROIVW as of Q4 2022.

  • Centiva Capital reported no remaining Roivant Sciences Ltd. Warrant position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 2,020,940 Roivant Sciences Ltd. Warrant shares in Q4 2022, an estimated $788K.
  • Centiva Capital first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 4 quarters.
  • Centiva Capital's Roivant Sciences Ltd. Warrant position peaked at $2.24M in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.